Published on:

Tylenol plant conditions called “shocking”

Recent findings are showing that the safety and quality violations that led to the Tylenol plant shutdown were extremely serious and can lead to extremely tough action by United States regulators on drugmaker Johnson & Johnson. Last week, the Food and Drug Administration (“FDA”) released an inspection report on the facility in Pennsylvania where the product recall stems from, which a professor of pharmaceutical manufacturer called “absolutely shocking.” According to the professor at Temple University, the inspection report “is pretty close to being the worst [he’s] seen. It suggests that basically the FDA found an issue with almost every system at the plant.”

Earlier this month, a division of Johnson & Johnson recalled nearly fifty children’s versions of non-prescription (over-the-counter) drugs, including Tylenol, Motrin, and Benadryl. Since then, Johnson & Johnson has suspended all production at the plant. The FDA report listed twenty violations, including dozens of consumer complaints on the products recalled. However, Johnson & Johnson has not revealed details of those complaints. Congress has opened a product liability investigation into the product recall and lawmakers gave Johnson & Johnson and the FDA a deadline of today (May 17) to hand over details about consumer complaints. The Illinois product liability attorneys will keep our readers posted as the details of this product recall involving millions of consumers unfolds.

Chicago injury attorneys at Levin & Perconti want to remind you that you can dispose of pharmaceuticals. The City of Chicago and the Chicago Police Department have partnered to provide a place for the safe and proper disposal of unused or expired prescription and over-the-counter medications.

Where to dispose of recalled and expired prescription and over-the-counter medications.

To read about the shocking conditions at the product facility.